CA2588670A1 - Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes - Google Patents

Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes Download PDF

Info

Publication number
CA2588670A1
CA2588670A1 CA002588670A CA2588670A CA2588670A1 CA 2588670 A1 CA2588670 A1 CA 2588670A1 CA 002588670 A CA002588670 A CA 002588670A CA 2588670 A CA2588670 A CA 2588670A CA 2588670 A1 CA2588670 A1 CA 2588670A1
Authority
CA
Canada
Prior art keywords
cell
cells
hiv
vector
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002588670A
Other languages
English (en)
Inventor
Susanna M. Raybak
Andrea Cara
Gabriele Luca Gusella
Dianne L. Newton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOVERNMENT OF United States, REPRESENTED BY SECRE
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Priority claimed from CA002261987A external-priority patent/CA2261987C/fr
Publication of CA2588670A1 publication Critical patent/CA2588670A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002588670A 1996-07-22 1997-07-17 Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes Abandoned CA2588670A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2205296P 1996-07-22 1996-07-22
US60/022,052 1996-07-22
CA002261987A CA2261987C (fr) 1996-07-22 1997-07-17 Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002261987A Division CA2261987C (fr) 1996-07-22 1997-07-17 Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes

Publications (1)

Publication Number Publication Date
CA2588670A1 true CA2588670A1 (fr) 1998-01-29

Family

ID=38433879

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002588670A Abandoned CA2588670A1 (fr) 1996-07-22 1997-07-17 Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes

Country Status (1)

Country Link
CA (1) CA2588670A1 (fr)

Similar Documents

Publication Publication Date Title
JP2752788B2 (ja) 感染および過剰増殖障害の為の組換え療法
JP2859252B2 (ja) 感染および過剰増殖障害の為の組換え療法
Chen et al. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes
US6555107B2 (en) Lentiviral nucleic acids and uses thereof
US7226780B2 (en) Lentivirus vector system
Gervaix et al. Multigene antiviral vectors inhibit diverse human immunodeficiency virus type 1 clades
JP2003511083A (ja) レンチウイルスの三重鎖ｄｎａ、並びにレンチウイルスの三重鎖ｄｎａを含有するベクター及び組換え細胞
US8691533B2 (en) Inducible gene expression
US6235881B1 (en) Polypeptides encoded by novel HIV-2 proviruses
US20050214258A1 (en) Vectors for delivering viral and oncogenic inhibitors
US5554528A (en) Compositions and methods for inhibition of HIV production
US6200811B1 (en) Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein
Inouye et al. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector
LARSSON et al. A Novel Ribozyme Target Site Located in the HIV-1NefOpen Reading Frame
Dimitrova et al. Lentivirus-mediated transduction of PKR into CD34+ hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny
Mautino et al. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev
WO1998003669A9 (fr) Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes
US6953687B1 (en) Vectors for delivering viral and oncogenic inhibitors
AU774551B2 (en) Vectors for delivering viral and oncogenic inhibitors
Ranga et al. Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene
CA2588670A1 (fr) Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes
OBARU et al. Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1
CA2047363C (fr) Therapies a base de recombinaison pour les infections et troubles hyperproliferatifs
JP3805371B2 (ja) 細胞にｈｉｖ重感染に対する抵抗性を与える組成物および方法
Duarte 77. HIV-1 Vector Production Mediated by Rev Protein Transduction

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead